摘要: Renal medullary carcinoma (RMC) is a rare and aggressive form of non-clear cell kidney cancer that typically affects young adults almost exclusively associated with sickle trait. It has only been recognized in the last two decades continues to be relatively poorly understood. Patients present pain hematuria are often found have metastatic disease at diagnosis. Prognosis extremely poor, mean survival less than 1 year. Combination chemotherapy used limited success. As we learn more about genetics disease, targeted therapy being attempted.